{"filing":{"accession_number":"0001171843-26-006215","cik":"0001801198","ticker":"LEGN","company_name":"Legend Biotech Corp","form":"6-K","filing_date":"2026-09-24","report_date":"2026-09-24","primary_document":"f6k_092326.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1801198/000117184326006215/f6k_092326.htm"},"events":[{"id":34849,"run_id":32087,"accession_number":"0001171843-26-006215","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This exhibit discloses the voting results from Legend Biotech's 2026 Annual General Meeting held on September 24, 2026, including shareholder approval of director re-elections, auditor ratification, and amendment to the 2020 Restricted Shares Plan to increase shares reserved for issuance by 19.1 million shares. The detailed vote tallies and percentages for each resolution are material to investors assessing governance and capital structure decisions.","company_name":"Legend Biotech Corp","ticker":"LEGN","filing_date":"2026-09-24","form":"6-K","submitted_at":null,"items":[{"id":38701,"accession_number":"0001171843-26-006215","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit discloses the voting results from Legend Biotech's 2026 Annual General Meeting held on September 24, 2026, including shareholder approval of director re-elections, auditor ratification, and amendment to the 2020 Restricted Shares Plan to increase shares reserved for issuance by 19.1 million shares. The detailed vote tallies and percentages for each resolution are material to investors assessing governance and capital structure decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:02:39.102639+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38701,"accession_number":"0001171843-26-006215","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This exhibit discloses the voting results from Legend Biotech's 2026 Annual General Meeting held on September 24, 2026, including shareholder approval of director re-elections, auditor ratification, and amendment to the 2020 Restricted Shares Plan to increase shares reserved for issuance by 19.1 million shares. The detailed vote tallies and percentages for each resolution are material to investors assessing governance and capital structure decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-24T20:02:39.102639+00:00","company_name":"Legend Biotech Corp","ticker":"LEGN","filing_date":"2026-09-24"}]}